text.skipToContent text.skipToNavigation
Need help? Please contact us
Pharma & Biotech

Human Naive CD4+/CD45RA+ T Cells (Cord Blood)

Catalog #: 4C-202
Human CD4+/CD45RA+ Naive T cells, isolated from cord blood using negative immunomagnetic selection, ≥ 5 million cells, cryopreserved

Product Overview

Cord blood from a single donor is used to negatively select Naïve T cells using a two step isolation process. CD4+ T Cells are first negatively selected from MNC using an indirect immunomagnetic CD4+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population. Cells are cryopreserved with Lonza Cryo Media in a cryovial. Purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Manufactured by AllCells®

Content & Storage


1 vial containing ≥ 5 million cryopreserved cells


Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Need a Quote or Any Support?

Request a local representative to get back to you with additional information or pricing.

Immunotherapy and Hematopoietic Knowledge Center

The Immunotherapy and Hematopoietic Knowledge Center is dedicated to sharing interesting articles and resources related to immuno and hematopoietic research.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.